BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12843779)

  • 1. The need for a "condoms-only" control group in microbicide trials.
    Jones H; van de Wijgert J; Kelvin E
    Epidemiology; 2003 Jul; 14(4):505; author reply 505-6. PubMed ID: 12843779
    [No Abstract]   [Full Text] [Related]  

  • 2. The design of prophylactic trials for HIV: the case of microbicides.
    Stein ZA; Myer L; Susser M
    Epidemiology; 2003 Jan; 14(1):80-3; discussion 83-4. PubMed ID: 12500050
    [No Abstract]   [Full Text] [Related]  

  • 3. The slow evolution of microbicides for STD/HIV prevention.
    Howes J; Bass M
    J Gend Specif Med; 1999; 2(3):22-3. PubMed ID: 11252848
    [No Abstract]   [Full Text] [Related]  

  • 4. AIDS research. Microbicide fails to protect against HIV.
    Cohen J
    Science; 2008 Feb; 319(5866):1026-7. PubMed ID: 18292313
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaginal microbicides.
    O'Brien RF
    Adolesc Med Clin; 2006 Oct; 17(3):673-85; abstract xi. PubMed ID: 17030285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbicide preference among young women in California.
    Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
    J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going?
    Elias C; Coggins C
    J Womens Health Gend Based Med; 2001 Mar; 10(2):163-73. PubMed ID: 11268299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews.
    Turner AN; De Kock AE; Meehan-Ritter A; Blanchard K; Sebola MH; Hoosen AA; Coetzee N; Ellertson C
    J Clin Epidemiol; 2009 Jul; 62(7):759-65. PubMed ID: 19013762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV trial doomed by design, say critics.
    Check E
    Nature; 2007 Jul; 448(7150):110-1. PubMed ID: 17625525
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV/AIDS. At last, vaginal gel scores victory against HIV.
    Cohen J
    Science; 2010 Jul; 329(5990):374-5. PubMed ID: 20643914
    [No Abstract]   [Full Text] [Related]  

  • 11. First real success for anti-HIV gel: a new start for HIV microbicides?
    Ariƫn KK; Vanham G
    Future Microbiol; 2010 Nov; 5(11):1621-3. PubMed ID: 21133683
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of microbicides and changes in condom usage on HIV prevalence in men and women.
    Chen FH
    AIDS; 2006 Jul; 20(11):1551-3. PubMed ID: 16847411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges to microbicide introduction in South Africa.
    Orner P; Harries J; Cooper D; Moodley J; Hoffman M; Becker J; McGrory E; Dabash R; Bracken H
    Soc Sci Med; 2006 Aug; 63(4):968-78. PubMed ID: 16600447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will vaginal microbicides solve the HIV problem in Africa?
    Muula AS
    Croat Med J; 2006 Dec; 47(6):895-8. PubMed ID: 17167863
    [No Abstract]   [Full Text] [Related]  

  • 16. Test of new vaginal microbicide gel show promise for women.
    AIDS Read; 2008 Apr; 18(4):165-6. PubMed ID: 18467997
    [No Abstract]   [Full Text] [Related]  

  • 17. Acceptability of a carrageenan-based candidate vaginal microbicide and matching placebo: findings from a phase II safety trial among women in Chiang Rai, Thailand.
    Jones HE; Chaikummao S; van de Wijgert JH; Friedland BA; Manopaiboon C; Witwatwongwana P; Wankrairot M; Chantharojwong N; Kilmarx PH
    J Womens Health (Larchmt); 2009 Jul; 18(7):1003-10. PubMed ID: 19575689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV microbicide trials halted.
    Wakabi W
    CMAJ; 2007 May; 176(11):1569-70. PubMed ID: 17515576
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices.
    Moench TR; Chipato T; Padian NS
    AIDS; 2001 Sep; 15(13):1595-602. PubMed ID: 11546933
    [No Abstract]   [Full Text] [Related]  

  • 20. Ongoing microbicide studies may lead to more options. Daily doses and a vaginal ring are being tried.
    AIDS Alert; 2010 Dec; 25(12):136-7. PubMed ID: 21328810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.